Neonatal Hydrocortisone Treatment for Prevention of Bronchopulmonary Dysplasia in High-Risk Preterm Infants: Impact on School-Age Functional Outcomes

Sara B.. DeMauro, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States; Haresh Kirpalani, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; Kristina Ziolkowski, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; Susan R. Hintz, Stanford University School of Medicine, Palo Alto, CA, United States; Kristi L. Watterberg, University of New Mexico School of Medicine, ALBUQUERQUE, NM, United States; Michael E. Msall, Comer Children's Hospital at University of Chicago Medical Center, Chicago, IL, United States; Victoria E. Watson, Women & Infants Hospital of Rhode Island, Providence, RI, United States; Jean R. Lowe, University of New Mexico School of Medicine, Albuquerque NM, NM, United States; Seetha Shankaran, The University of Texas at Austin, Ann Arbor, MI, United States; Sanjay Chawla, Children's Hospital of Michigan, TROY, MI, United States; Betty R. Vohr, Women & Infants Hospital/ Brown Medical School, Providence, RI, United States; Bradley A. Yoder, University of Utah School of Medicine, Salt Lake City, UT, United States; Khanh V. Lai, University of Utah, Salt Lake City, UT, United States; Sarah Winter, University of Utah School of Medicine, Salt Lake City, UT, United States; Tarah Colaizy, University of Iowa Stead Family Children's Hospital, Iowa City, IA, United States; Stephanie L. Merhar, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Carla Bann, RTI International, Apex, NC, United States; Marissa Trotta, RTI International, Hillsborough, NC, United States; Jamie E. Newman, RTI International, Carrboro, NC, United States; Carl T. D'Angio, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States; Abhik Das, RTI International, North Potomac, MD, United States